Related Experiment Video

Updated: Aug 25, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

Dendritic cells become BCR-ABL negative in chronic myeloid leukaemia patients successfully treated with imatinib

L Wang, N M Butt, M G Atherton

    Leukemia
    |March 12, 2004
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
    08:05

    Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

    Published on: March 17, 2020

    Related Experiment Videos

    Last Updated: Aug 25, 2026

    Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
    10:09

    Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

    Published on: January 7, 2019

    Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
    08:05

    Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

    Published on: March 17, 2020

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...

    Articles linked to this work by shared authors, journal, and citation graph.

    Prodomain mutations at the subtilisin interface: correlation of binding energy and the rate of catalyzed folding.

    Biochemistry·1995

    Thermodynamic parameters for the helix-coil transition of oligopeptides: molecular dynamics simulation with the peptide growth method.

    Proceedings of the National Academy of Sciences of the United States of America·1995

    The sixty nucleotide OccR operator contains a subsite essential and sufficient for OccR binding and a second subsite required for ligand-responsive DNA bending.

    Journal of molecular biology·1995

    Cloning of a cDNA encoding a 190-kDa insulin receptor substrate-1-like protein of simian COS cells.

    Biochemical and biophysical research communications·1995

    Differences in oxidative response of subpopulations of neutrophils from healthy subjects and patients with rheumatoid arthritis.

    Annals of the rheumatic diseases·1995

    Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat.

    The Journal of biological chemistry·1995

    First-line ibrutinib-venetoclax in chronic lymphocytic leukemia: GLOW 67-month results and grade 3/4 adverse event-free progression-free survival.

    Leukemia·2026

    Inhibition of ROR1 signaling with zilovertamab plus ibrutinib in chronic lymphocytic leukemia: safety, mechanistic insights, and an exploratory signal in del(17p) disease.

    Leukemia·2026

    Alterations in 3D-DNA architecture drive unique leukemic profiles in IDH1- and DNMT3A-mutant acute myeloid leukemia.

    Leukemia·2026

    Exploiting an epigenetic resistance mechanism to PI3-kinase inhibition in leukemic stem cells.

    Leukemia·2026

    PIM1 in myeloproliferative neoplasms: potential pathogenic and therapeutic implications.

    Leukemia·2026

    Clinical and molecular characteristics of clonal monocytosis with and without cytopenia(s).

    Leukemia·2026

    Outcomes of Long-Term Absorbable Mesh Use for Ventral Hernia Repair in Immunosuppressed Patients.

    World journal of surgery·2026

    Simultaneous Quantification of Vedolizumab, Ustekinumab, and Infliximab in Human Serum by LC-MS/MS: Application to Therapeutic Drug Monitoring in Inflammatory Bowel Disease.

    Drug design, development and therapy·2026

    Bispecific antibodies that engage pIgR enrich in mucosa in cynomolgus monkeys.

    mAbs·2026

    Infection Prevention and Management in Patients With Multiple Myeloma Treated With Bispecific Antibodies: A Case-Based Approach for Routine Clinical Practice.

    Clinical lymphoma, myeloma & leukemia·2026

    Anti-CD20 monoclonal antibodies in membranous nephropathy.

    Nefrologia·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us